| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2008 | WO2008149971A1 Therapeutic or prophylactic agent for cerebral aneurysm |
| 12/11/2008 | WO2008149965A1 Pyridone compound |
| 12/11/2008 | WO2008149838A1 Novel fractionation product of royal jelly, method for production of the same, and use of the same |
| 12/11/2008 | WO2008149834A1 Pyrimidodiazepinone derivative |
| 12/11/2008 | WO2008149802A1 Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient |
| 12/11/2008 | WO2008149601A1 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 12/11/2008 | WO2008149521A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/11/2008 | WO2008149382A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 12/11/2008 | WO2008149379A2 Novel compounds |
| 12/11/2008 | WO2008149353A2 Telomerase activating compounds and methods of use thereof |
| 12/11/2008 | WO2008149338A2 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists |
| 12/11/2008 | WO2008149311A1 Use of derivatives of 3-oxo-2,3-dihydro-5h-thiazolof[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5h-selenazolo[3,2-a]pyrimidine or of 3-oxo-1,2,3-trihydro-5h-imidazolo[1,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer |
| 12/11/2008 | WO2008149283A1 Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| 12/11/2008 | WO2008149230A2 Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
| 12/11/2008 | WO2008149204A1 An improved process for preparing an optically active proton pump inhibitor |
| 12/11/2008 | WO2008149201A2 Stable pharmaceutical composition |
| 12/11/2008 | WO2008149192A2 Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
| 12/11/2008 | WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 12/11/2008 | WO2008149177A2 Marine lipid compositions and uses thereof |
| 12/11/2008 | WO2008149168A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 12/11/2008 | WO2008149160A1 Amorphous olmesartan medoxomil |
| 12/11/2008 | WO2008149155A1 Crystalline form b of olmesartan medoxomil |
| 12/11/2008 | WO2008149154A2 Tegaserod succinate and polymorphic forms |
| 12/11/2008 | WO2008149152A1 Novel process |
| 12/11/2008 | WO2008149140A2 Tegaserod oxalate and polymorphic forms |
| 12/11/2008 | WO2008149139A2 Tegaserod fumarate and polymorphic forms |
| 12/11/2008 | WO2008149138A1 Tegaserod malate and polymorphic forms |
| 12/11/2008 | WO2008149137A2 Tegazerod benzoate and polymorphic forms |
| 12/11/2008 | WO2008149136A1 Tegaserod besylate and polymorphic forms |
| 12/11/2008 | WO2008149110A1 Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated |
| 12/11/2008 | WO2008149103A1 Methods of assessing and treating multiple-organ failure |
| 12/11/2008 | WO2008149089A1 Antimicrobial formulations comprising a combination of a pyridine thiol and a bis-quinolinium salt |
| 12/11/2008 | WO2008149062A1 Buspirone for the treatment of nausea and vomiting |
| 12/11/2008 | WO2008149053A1 Bicycl0 [2. 2. 1] he pt- 2-ylamine derivates and their use |
| 12/11/2008 | WO2008149036A1 Novel agent for salting out active principles in dressings containing at least one fatty substance |
| 12/11/2008 | WO2008149035A2 Novel active ingredient in cicatrization and use thereof |
| 12/11/2008 | WO2008148968A1 Dermatological and cosmetic depigmenting compositions, methods for the preparation thereof and uses thereof |
| 12/11/2008 | WO2008148967A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
| 12/11/2008 | WO2008148966A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof |
| 12/11/2008 | WO2008148892A2 Mc- i r, mc-2 r, and mu opioid receptors modulation |
| 12/11/2008 | WO2008148879A2 Use of a substance to improve postoperative outcome after end-to-end reconstruction of peripheral nerves |
| 12/11/2008 | WO2008148873A2 Hydroxyproline compositions and uses thereof |
| 12/11/2008 | WO2008148868A1 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 12/11/2008 | WO2008148851A1 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148849A2 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148840A1 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148836A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 12/11/2008 | WO2008148832A1 Compounds which potentiate ampa receptor and uses therof in medicine |
| 12/11/2008 | WO2008148812A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
| 12/11/2008 | WO2008148799A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 12/11/2008 | WO2008148790A1 Anti -inflammatory substituted cyclobutenedione compounds |
| 12/11/2008 | WO2008148747A2 Pdz domain modulators |
| 12/11/2008 | WO2008148744A1 Thiadiazole derivatives as antidiabetic agents |
| 12/11/2008 | WO2008148710A2 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity |
| 12/11/2008 | WO2008148689A1 Prolinamide derivatives as nk3 antagonists |
| 12/11/2008 | WO2008148688A1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists |
| 12/11/2008 | WO2008148617A1 Beta-carboline arylsulfonamides, method for preparing them and composition comprising them |
| 12/11/2008 | WO2008148599A2 Process for obtaining a valsartan salt useful for obtaining valsartan |
| 12/11/2008 | WO2008148573A2 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms |
| 12/11/2008 | WO2008148564A1 Neramexane for the treatment of nystagmus |
| 12/11/2008 | WO2008148515A1 Intranasal administration of asenapine and pharmaceutical compositions therefor |
| 12/11/2008 | WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 12/11/2008 | WO2008148449A1 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors |
| 12/11/2008 | WO2008148359A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 12/11/2008 | WO2008148303A1 A composition for treating vegetative dystonine syndrome and pharmaceutical preparation and application thereof |
| 12/11/2008 | WO2008148302A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof |
| 12/11/2008 | WO2008148292A1 An ophthalmic, otic or nasal composition and its use |
| 12/11/2008 | WO2008148279A1 Cyclobutyl-fused pyrrolidine derivatives, their preparation methods and their medical use |
| 12/11/2008 | WO2008148269A1 Anti-tumor medicine containing betulinic acid derivatives |
| 12/11/2008 | WO2008148260A1 A novel crystal form of irinotecan hydrochloride and its preparation |
| 12/11/2008 | WO2008148216A1 Drak2 expression is associated with diabetes |
| 12/11/2008 | WO2008148215A1 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 12/11/2008 | WO2008130632A3 Methods of increasing camp levels and uses thereof |
| 12/11/2008 | WO2008129303A3 Sustained release |
| 12/11/2008 | WO2008128791A3 Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen |
| 12/11/2008 | WO2008128171A3 Diazo bicyclic smac mimetics and the uses thereof |
| 12/11/2008 | WO2008127647A3 Antagonists of the transient receptor potential vanilloid 1 and uses thereof |
| 12/11/2008 | WO2008127300A3 Oxazolidinone derivatives and methods of use |
| 12/11/2008 | WO2008124009A3 Treating glaucoma |
| 12/11/2008 | WO2008123800A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles |
| 12/11/2008 | WO2008122049A3 Methods and compositions for reduction of side effects of therapeutic treatments |
| 12/11/2008 | WO2008119825A3 Imidazolidine carboxamide derivatives as p2x7 modulators |
| 12/11/2008 | WO2008116815A3 Compounds |
| 12/11/2008 | WO2008116665A8 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 12/11/2008 | WO2008115225A3 Methods and compositions for treating fish diseases |
| 12/11/2008 | WO2008113863A3 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 12/11/2008 | WO2008112824A3 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels |
| 12/11/2008 | WO2008112199A8 Method for inhibiting topoisomerase ii |
| 12/11/2008 | WO2008111956A3 Fatty acid oxidation inhibitors treating hyperglycemia and related disorders |
| 12/11/2008 | WO2008110491A3 Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| 12/11/2008 | WO2008109560A3 Amelioration of cellular stress response |
| 12/11/2008 | WO2008109516B1 Nucleic acid compounds for inhibiting ras gene expression and uses thereof |
| 12/11/2008 | WO2008109454A3 Nucleic acid compounds for inhibiting fos gene expression and uses thereof |
| 12/11/2008 | WO2008109447B1 Nucleic acid compounds for inhibiting met gene expression and uses thereof |
| 12/11/2008 | WO2008109375A9 Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof |
| 12/11/2008 | WO2008109368A3 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof |
| 12/11/2008 | WO2008109357B1 Nucleic acid compounds for inhibiting apob gene expression and uses thereof |